Industry / Czech Republic
Teva Invests In Ivax Plant
March 2008 | Industry NewsIsraeli generics firm Teva is planning to invest US$100mn in one of its facilities in Northern Moravia, in the Czech Republic, with the aim of trebling production there over the next three years.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
